LINEAGE CELL THERAPEUTICS INC COM is a security (CUSIP 53566P109) tracked across SEC portfolio filings. 137 institutional managers reported $181.7M on Form 13F as of 2026-06-30; 5 registered fund positions totaling $4.4M via N-PORT as of 2026-05-29.
Showing 15 of 137 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| BROADWOOD CAPITAL INC | New York, NY | $78.3M | 49,560,992 |
| VANGUARD GROUP INC | Valley Forge, PA | $16.1M | 9,644,276 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $8.8M | 5,561,374 |
| Defender Capital, LLC. | CHARLOTTE, NC | $8.6M | 6,598,899 |
| RAFFLES ASSOCIATES LP | NEW YORK, NY | $8.5M | 5,362,788 |
| COMERICA BANK | DALLAS, TX | $7.7M | 4,600,000 |
| BlackRock, Inc. | New York, NY | $6.1M | 3,864,757 |
| FIFTH THIRD BANCORP | CINCINNATI, OH | $6.0M | 4,600,000 |
| ARMISTICE CAPITAL, LLC | NEW YORK, NY | $5.0M | 3,182,799 |
| MARSHALL WACE, LLP | LONDON, X0 | $4.8M | 3,065,033 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $4.0M | 2,523,114 |
| RENAISSANCE TECHNOLOGIES LLC | NEW YORK, NY | $3.4M | 2,125,100 |
| MORGAN STANLEY | NEW YORK, NY | $3.0M | 1,868,491 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | BALA CYNWYD, PA | $2.2M | 1,304,685 |
| UBS Group AG | Zurich, V8 | $2.2M | 1,370,461 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $4.1M | 0.50% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $148K | 0.05% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $146K | 0.02% |
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $994 | 0.02% |
| Blackstone Alternative Multi-Strategy Fund | Blackstone Alternative Investment Funds | $-790 | -0.00% |